Status:
UNKNOWN
Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure
Lead Sponsor:
Peking University People's Hospital
Conditions:
Infertility, Female
Mitochondrial
Eligibility:
FEMALE
35+ years
Phase:
NA
Brief Summary
The goal to this clinical trial is to study the effectiveness and safety of automitochondrial transplantation of urine derived stem cells(USCs) in in elderly patients with low prognosis after repeated...
Eligibility Criteria
Inclusion
- 1\) At least 35 years old
- 2\) Repeated IVF failure: more than or equal to 2 egg retrieval with poor embryo quality, no transplanted embryos or failed embryo transfer (more than or equal to 4 embryos)
- 3\) Egg number ≤9
- 4\) Participate voluntarily and sign informed consent.
Exclusion
- 1: Infertility caused by severe oligospermia, severe intrauterine adhesions, genital tract malformations, thyroid dysfunction and other endocrine, immune system, tumor and genetic diseases
Key Trial Info
Start Date :
February 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06020742
Start Date
February 9 2023
End Date
December 31 2024
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's hospital
Beijing, Beijing Municipality, China